Rin Institute Inc.

National Cancer Center

National Cancer Center Japan

Order-made Medical Research Inc.

Shingo Hanaoka

Yasuhiro Matsumura

Masahiro Yasunaga

Shinji Saijou

Shino Manabe

Hiroyuki Satofuka

Shinji Saijo

Masahiro Uchino

Takahiro Anzai

An object of the present invention is to provide an anticancer drug capable of treating cancer by finding a target molecule specifically expressed in cancer cells and by specifically acting on the target molecule, and to provide a cancer testing method including a step of measuring the target molecule in a sample. The present invention provides an anticancer drug containing, as an active ingredient thereof, an anti-transmembrane protein 180 (TMEM-180) antibody or an antigen-binding fragment thereof. In addition, the present invention provides a cancer testing method including a step of measuring the amount of TMEM-180 in a sample collected from a subject.

Anti-TMEM-180 antibody, anticancer drug and cancer testing method

Cancer-cell-specific anti-TMEM-180 monoclonal antibody, anticancer drug, and cancer testing method

[Problem] The present invention provides an antibody that binds to TMEM132A, an anticancer agent and a cancer test method. [Solution] An antibody that binds to TMEM132A.

Antibody binding to TMEM132A, anticancer agent, and cancer test method

Cancer-cell-specific anti-transmembrane protein 180 antibody, anticancer drug, and cancer testing method

The present invention aims to provide a method for antibody preparation. The present invention is directed to a method for preparing an antibody-producing cell, which comprises the following steps:

Method of producing an antibody using a cancer cell

Growing community of inventors

Tokyo, Japan

Shingo Hanaoka